STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Stemtech Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $207.74K
- P/E (TTM)
- –
- Dividend yield
- –
Stemtech statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Wholesale-Drugs, Proprietaries & Druggists' Sundries companies for comparison
Valuation
| Measure | Stemtech | Industry median |
|---|---|---|
| Market Cap | $299.70K | $71.31M |
| Enterprise Value | -$692.83K | $153.86M |
| PS Ratio | 0.12 | 0.28 |
Enterprise value
| Measure | Stemtech | Industry median |
|---|---|---|
| EV / Sales | -0.29 | 0.40 |
Income (trailing twelve months)
| Measure | Stemtech | Industry median |
|---|---|---|
| Revenue | $2.40M | $716.39M |
| Gross Profit | $1.86M | $163.57M |
| Operating Income | -$2.42M | -$30.27K |
| Pretax Income | -$3.84M | $413.10K |
| Net Income | -$3.84M | -$63.82K |
| EBITDA | -$2.26M | $2.60M |
| EPS (Diluted) | -$0.02 | $0.02 |
Margins
| Measure | Stemtech | Industry median |
|---|---|---|
| Gross Margin | 77.3% | 14.7% |
| Operating Margin | -100.8% | 0.44% |
| Pretax Margin | -159.8% | 0.25% |
| Profit Margin | -159.7% | -0.13% |
| EBITDA Margin | -93.9% | 1.23% |
| FCF Margin | -13.7% | 0.98% |
Returns
| Measure | Stemtech | Industry median |
|---|---|---|
| Return on Assets (ROA) | -109.1% | -0.67% |
Growth
| Measure | Stemtech | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -38.6% | 3.83% |
| Revenue Growth (3Y CAGR) | -14.2% | 0.59% |
Balance sheet
| Measure | Stemtech | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $246.77K | $9.33M |
| Total Debt | $0 | $349.35M |
| Net Cash (Debt) | $246.77K | -$1.85M |
| Net Cash Per Share | $0.00 | -$0.06 |
| Equity (Book Value) | -$7.47M | $16.46M |
| Book Value Per Share | -$0.00 | $0.34 |
| Tangible Book Value | -$10.06M | $8.19M |
| Working Capital | -$10.54M | $12.53M |
Financial position
| Measure | Stemtech | Industry median |
|---|---|---|
| Current Ratio | 0.05 | 1.31 |
| Quick Ratio | 0.02 | 0.55 |
| Interest Coverage | -1.81 | 0.82 |
Cash flow (trailing twelve months)
| Measure | Stemtech | Industry median |
|---|---|---|
| Operating Cash Flow | -$328.76K | $3.55M |
| Capital Expenditures | $0 | -$34.65M |
| Free Cash Flow | -$328.76K | $15.14M |
| FCF Per Share | -$0.00 | $0.38 |
Efficiency
| Measure | Stemtech | Industry median |
|---|---|---|
| Asset Turnover | 0.68 | 1.65 |
| Inventory Turnover | 1.86 | 9.79 |
Dividends and yields
| Measure | Stemtech | Industry median |
|---|---|---|
| Earnings Yield | -1280.3% | -0.30% |
| FCF Yield | -109.7% | 4.46% |
| Buyback Yield | 0.00% | 0.28% |
| Shareholder Yield | 0.00% | 0.83% |
Shares
| Measure | Stemtech | Industry median |
|---|---|---|
| Shares Outstanding | 2,997,030,000 | 32,773,350 |
| Shares Change (YoY) | 537.6% | 0.00% |
| Shares Change (QoQ) | 66.0% | 0.00% |
| Float | 2,994,900,000 | 22,533,950 |
| Shares Held by Insiders | 0.07% | 8.34% |
Taxes
| Measure | Stemtech | Industry median |
|---|---|---|
| Income Tax | $0 | $3.29M |
Scores
| Measure | Stemtech | Industry median |
|---|---|---|
| Altman Z-Score | -21.83 | 3.72 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Stemtech's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.